Sign In
Buy NUVA
$39.75
+0 (+0%)
At Close: Nov 30, 2023
NuVasive to Participate in UBS Virtual Global Healthcare Conference
08:03pm, Tuesday, 12'th May 2020
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that manag
Symphony Asset Management Llc Buys RingCentral Inc, Twilio Inc, Atlassian Corporation PLC, ...
12:00am, Tuesday, 12'th May 2020New Strong Sell Stocks for May 11th
01:28pm, Monday, 11'th May 2020
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
NuVasive Inc (NUVA) Q1 2020 Earnings Call Transcript
08:00pm, Thursday, 07'th May 2020
Image source: The Motley Fool. NuVasive Inc (NASDAQ: NUVA)Q1 2020 Earnings CallMay 6, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operat
Canaccord Genuity Maintains Buy on NuVasive, Lowers Price Target to $64
05:54pm, Thursday, 07'th May 2020Citigroup Maintains Neutral on NuVasive, Raises Price Target to $58
04:48pm, Thursday, 07'th May 2020UBS Maintains Sell on NuVasive, Lowers Price Target to $55
04:32pm, Thursday, 07'th May 2020NuVasive's (NUVA) Q1 Earnings Beat Estimates, Revenues Miss
02:53pm, Thursday, 07'th May 2020
NuVasive's (NUVA) operating segments experience slowdown in first-quarter volumes due to the coronavirus pandemic.
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Lyft, Solaredge Technologies
07:34am, Thursday, 07'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge
Technologies, on Thursday.
HIG
Edited Transcript of NUVA earnings conference call or presentation 6-May-20 8:30pm GMT
05:37am, Thursday, 07'th May 2020
Q1 2020 NuVasive Inc Earnings Call
NuVasive (NUVA) Beats Q1 Earnings and Revenue Estimates
10:35pm, Wednesday, 06'th May 2020
NuVasive (NUVA) delivered earnings and revenue surprises of 37.14% and 0.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NuVasive Withdraws Its FY20 Guidance Due To Coronavirus
08:31pm, Wednesday, 06'th May 2020NuVasive Q1 EPS $0.480 Beats $0.430 Estimate, Sales $259.900M Miss $273.880M Estimate
08:30pm, Wednesday, 06'th May 2020NuVasive Announces First Quarter 2020 Financial Results
08:02pm, Wednesday, 06'th May 2020
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial
